Investment Rating - The report initiates coverage with a "Buy" rating for the company [9]. Core Insights - The company is positioned as a leading provider of chemical technology solutions, focusing on agricultural CDMO, pharmaceutical small molecules, and small nucleic acid CDMO, with significant achievements in functional chemicals [3][5]. - The agricultural sector is experiencing steady growth, while the pharmaceutical CDMO sector shows promising prospects, particularly in small nucleic acids, which are gaining traction in the market [6][7]. - The company is expanding its footprint in the new energy sector, particularly in lithium battery materials, which presents substantial growth potential [8]. Summary by Relevant Sections Company Overview - Founded in 1985 and located in Taizhou, Zhejiang Province, the company has evolved from producing flavor and fragrance intermediates to becoming a global custom manufacturing service provider in agriculture, pharmaceuticals, and functional chemicals [5][19]. - The company has established a comprehensive business platform that meets diverse customer needs across various stages of product development and lifecycle [21][24]. Agricultural Sector - The global agricultural industry is entering a mature phase, with projected sales of $77.2 billion in 2024, reflecting a 6.8% year-over-year decline. However, the sector is expected to expand steadily due to ongoing population growth [6][53]. - The competitive landscape is characterized by oligopolistic structures, with the top five companies holding a 57.4% market share in 2024, driven by innovation and strong brand channels [6][53]. Pharmaceutical CDMO - The company has been involved in small molecule CDMO for over a decade, with a robust revenue growth trajectory since 2017. A significant rebound is expected in 2025, with projected revenue of 1.018 billion yuan, a 42.8% increase year-over-year [7]. - The company is expanding into the small nucleic acid drug market, which is projected to see 32 transactions worth $29.022 billion in 2025, highlighting the growing commercial value of this segment [7]. Functional Chemicals - The lithium-ion battery electrolyte market is rapidly growing, with expected shipments reaching 2.235 million tons by 2025, a 46.4% increase. The company is focusing on lithium hexafluorophosphate and lithium bis(fluorosulfonyl)imide as key products in this sector [8][24]. - The company is well-positioned to capitalize on the increasing demand for lithium battery materials, with a focus on developing high-performance products [8]. Financial Performance - The company is expected to achieve net profits of 410 million, 630 million, and 790 million yuan for the years 2025 to 2027, respectively, indicating strong financial growth prospects [9].

硅宝科技（300019）(300019.SZ)披露2025年度业绩快报，公司实现营业收入37.52亿元，同比增长 18.76%;归属上市公司股东的净利润2.81亿元，同比增长18.34%。公司全年产销量再创新高，全年销售 重量30.75万吨，同比增长25.45%。 ...

证券日报网讯 2月4日，凌玮科技在互动平台回答投资者提问时表示，公司的消光剂可以降低光的全反 射，有降低光污染的作用。公司产品广泛应用于涂料、油墨、3C电子、光伏、塑料、石化、医用胶片 等行业，终端客户分布于工业制造、木器、家具、皮革、纺织、卷材、喷墨相纸、广告耗材、轨道交 通、UV、风电叶片、塑料薄膜等应用领域，并进入防火耐高温材料、金属表处剂、工业防腐、陶瓷、 蓄电池、精密基材抛光液、太阳能电池涂覆背板膜、饮料澄清剂、医用胶片、医用手套、电子电路基 板、电子封装、HBM封装和电子胶粘结剂塑料粒子等新的应用领域。公司将持续关注并积极参与光污 染行业的发展，致力于为行业提供环保、高效的新材料解决方案。 （文章来源：证券日报） ...

冠城新材（600067.SH）2月4日在投资者互动平台表示，目前邵武创鑫一、二期总年产能约900吨，不 同产品产能不同，后续公司将根据市场需求确定是否增加产能。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：请问贵公司电解液添加剂年产能有多少吨，是否有增 加产能的计划？ ...

华创证券研报指出，天赐材料2025年Q4超预期，业绩拐点已至。公司年报预告预计归母净利润11~16亿 元，同比增长127.31%~230.63%，上年同期仅4.8亿元。Q4单季净利润约为9.3亿元，同比增长536%，环 比507%，Q4实现较大幅度增长，超预期。六氟价格高涨，公司有多订单项目签订。固态电池布局进展 顺利。公司主要以硫化物作为固态电解质的主要路线。六氟磷酸锂与电解液价格均已走出底部，公司 2025Q4业绩显著改善，预计2026年有较大增长。参考可比公司估值，给予公司2026年15xPE，对应目标 价59.74元，维持"强推"评级。 ...

证券之星消息，2月4日化学制品板块较上一交易日上涨0.43%，山东赫达领涨。当日上证指数报收于 4102.2，上涨0.85%。深证成指报收于14156.27，上涨0.21%。化学制品板块个股涨跌见下表： 从资金流向上来看，当日化学制品板块主力资金净流出14.05亿元，游资资金净流入1.32亿元，散户资金 净流入12.73亿元。化学制品板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 002810 山东赫达 | | 1.23 Z | 27.09% | -5719.68万 | -12.62% | -6553.95万 | -14.47% | | 301286 侨源股份 | | 5835.98万 | 18.73% | 276.62万 | 0.89% | -6112.61万 | -19.62% | | 603334 丰倍生物 | | 5480.84万 | 24.33% | -2168.61万 | -9 ...

格隆汇2月4日丨新化股份(603867.SH)在投资者互动平台表示，公司在萃取技术方面拥有扎实的研发积 累，目前在锂电池材料回收等领域已实现成熟应用，能够高效提取锂、镍、钴、锰等金属。关于磷元素 提取，公司在实验室层面已具备相应的技术能力，但尚未实现工业化应用。 ...

Core Viewpoint - SuBot's stock price has experienced a decline of 9.29% over the last three days, closing at 12.31 CNY per share with a market capitalization of 5.248 billion CNY [1] Group 1: Company Overview - SuBot, established on December 15, 2004, and listed on November 10, 2017, is located in Nanjing, Jiangsu Province, specializing in the research, production, and sales of concrete additives [1] - The revenue composition of SuBot includes: high-performance water reducers (51.83%), functional materials (20.74%), technical services (20.21%), others (5.53%), high-efficiency water reducers (1.15%), and additional (0.55%) [1] Group 2: Shareholder Insights - The top circulating shareholder of SuBot includes a fund from China Merchants Fund, specifically the China Merchants Quantitative Selected Stock Fund A (001917), which holds 2.7122 million shares, accounting for 0.65% of circulating shares [2] - The fund has incurred a floating loss of approximately 1.8172 million CNY today and a total of 3.6072 million CNY over the last three days [2] - The fund was established on March 15, 2016, with a current scale of 3.692 billion CNY and has achieved a year-to-date return of 5.42% [2] Group 3: Fund Performance - Another fund, the China Merchants CSI 2000 Enhanced Strategy ETF (159552), has increased its holdings in SuBot by 16,500 shares, totaling 490,900 shares, which represents 0.86% of the fund's net value [3] - This fund has also faced a floating loss of about 328,900 CNY today and 652,900 CNY over the last three days [3] - The ETF was established on June 19, 2024, with a current scale of 542 million CNY and has recorded a year-to-date return of 8.24% [3]

Core Viewpoint - Wanhua Chemical's stock has shown a mixed performance in recent trading, with a year-to-date increase of 10.98% but a decline of 2.53% over the last five trading days [1] Group 1: Stock Performance - As of February 4, Wanhua Chemical's stock price was 85.10 CNY per share, with a market capitalization of 266.4 billion CNY [1] - The stock experienced a net inflow of 24.8 million CNY from main funds, with significant buying and selling activity [1] - Over the past 60 days, the stock has increased by 25.41% [1] Group 2: Financial Performance - For the period from January to September 2025, Wanhua Chemical reported a revenue of 144.23 billion CNY, a year-on-year decrease of 2.29% [2] - The net profit attributable to shareholders for the same period was 9.16 billion CNY, down 17.45% year-on-year [2] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 9.49% to 243,600, while the average number of tradable shares per person increased by 10.16% to 12,850 shares [2] - The company has distributed a total of 50.24 billion CNY in dividends since its A-share listing, with 14.05 billion CNY distributed in the last three years [3]

Group 1 - On February 3, Jinhe Industrial's stock rose by 3.88%, with a trading volume of 225 million yuan [1] - The financing data shows that on the same day, Jinhe Industrial had a financing purchase amount of 16.575 million yuan and a financing repayment of 28.278 million yuan, resulting in a net financing outflow of 11.703 million yuan [1] - As of February 3, the total balance of margin trading for Jinhe Industrial was 654 million yuan, with the financing balance accounting for 4.93% of the circulating market value, indicating a high level compared to the past year [1] Group 2 - Jinhe Industrial, established on December 25, 2006, and listed on July 7, 2011, specializes in the research, production, and sales of food additives, functional chemical products, and various high-end intermediates, serving multiple industries [2] - The company's revenue composition includes 48.10% from food additives, 37.84% from bulk chemicals, 5.34% from functional chemical products and intermediates, and smaller percentages from other categories [2] - For the period from January to September 2025, Jinhe Industrial reported a revenue of 3.543 billion yuan, a year-on-year decrease of 12.35%, and a net profit attributable to shareholders of 391 million yuan, down 4.44% year-on-year [2] Group 3 - Since its A-share listing, Jinhe Industrial has distributed a total of 3.017 billion yuan in dividends, with 1.005 billion yuan distributed in the last three years [3] - As of September 30, 2025, the number of shareholders of Jinhe Industrial increased by 14.63% to 39,000, while the average circulating shares per person decreased by 12.76% to 14,516 shares [2][3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the second-largest shareholder with 12.904 million shares, a decrease of 749,600 shares from the previous period [3]